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ABSTRACT
PURPOSE:  To verify the correlation between the presence of IH and the intensity of LUTS related to BPH quantified through the
International Prostate Symptom Score (IPSS).
METHODS: We prospectively selected 52 patients over the age of 55years; Patients were divided into 2 groups. Group 1: composed
of 32 patients with IH; Group 2 (control group): composed of 20 patients with no clinical evidence of IH. All patients were assessed
using the IPSS, uroflowmetry (Qmax), post-void residual urine volume (PVR) and prostate volume (PV).
RESULTS: Groups 1 and 2 presented no difference in PV (p>0.05) and uroflowmetry (Qmax) (p>0.05). There was a statistical
significant difference between the PVR mean values between groups 1 and 2. The presence of IH correlated with a higher IPSS score
(r=0.38 p<0.05) despite the fact the no difference was detected between the incidence of patients with mild, moderate and severe LUTS
in groups 1 and 2.
CONCLUSION: Patients with IH present higher IPSS. The role of IPSS as a marker to predict the development of clinical IH still to
be determined.
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RESUMO
OBJETIVO: Verificar a correlação entre a presença de HI e a intensidade dos STUI quantificados através do escore internacional de
sintomas prostáticos (IPSS).
MÉTODOS: Foram selecionados prospectivamente 52 pacientes com idade superior a 55 anos; os pacientes foram divididos em 2
grupos. Grupo 1: composto por 32 pacientes portadores de IH, Grupo 2 (grupo controle): composto por 20 pacientes sem evidência
clínica de IH. Os parâmetros avaliados foram: sintomas urinários, quantificados através do IPSS; fluxo urinário máximo (Qmax),
obtido através da fluxometria livre; resíduo pós miccional (RM) e volume prostático (VP), obtido através do ultrassom transretal.
RESULTADOS: Os grupos 1 e 2 não apresentaram diferença significativa em relação ao Qmax e VP (p>0.05). Foi detectada diferença
estatística significativa entre em relação ao VR entre os grupos 1 e 2 (p<0.05). A presença de HI se correlacionou com o aumento da
intensidade dos STUI (r=0,38; p<0.05). Não foi detectada diferença estatisticamente significativa entre a incidência de pacientes
portadores de STUI, leve, moderado ou intenso entre os grupos 1 e 2.
CONCLUSÃO: Pacientes portadores de HI apresentam escore de sintomas (IPSS) mais elevados, entretanto o papel dos sintomas
urinários como um dos possíveis fatores causadores do aparecimento de HI ainda não foi determinado.
Descritores: Hernia Inguinal. Sistema Urinário. Sintomas. Questionários.
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Introduction
Lower urinary tract symptoms (LUTS) are prevalent
among aging men. Multiple etiologic factors have been described
with the genesis of urinary symptoms, including the effect of aging
on the nervous system and bladder, metabolic derangements,
changes in fluid regulation, obstruction and autonomic
overactivity1.
Histologic benign prostatic hyperplasia (BPH) develops
also with advancing age. Initial development of microscopic BPH
begins as early as 25 – 30 years. After the age of 45 the prevalence
of BPH increases rapidly, reaching 90% at the age of 90. However
macroscopic BPH (prostatic enlargement due to BPH) will be
detected eventually in half of man with microscopic BPH.
Traditionally, the diagnostic evaluation of patients with
LUTS suggestive of bladder outlet obstruction (BOO) includes
symptomatic evaluation2. Although symptom scoring systems have
proved to be a useful tool to quantify clinical symptoms, several
studies have shown that none of these scores correlate with BOO
and BPH related complications, furthermore they are not disease
specific3-5.
The incidence of inguinal hernias (IH) also increases with
age. Various factors contribute to the development of IH, including
obesity and work-related physical activity and is not uncommon
for urologists to face patients presenting LUTS associated to IH6.
The American Urological Association guideline, for BPH,
updated in 2006, recommends prostate surgery as first option just
for patients presenting refractory retention, gross hematuria,
bladder stones, recurrent urinary tract infection and renal
insufficiency, all clearly related to BPH7. No recommendations
are made in men with concomitant evidence of IH and bothersome
LUTS related to BPH.
The aim of this study is to verify the correlation between
the presence of IH and the intensity of LUTS, related to BPH,
quantified through the IPSS.
Methods
Between December 2004 and February 2006 we
prospectively selected 52 patients over the age of 50 years. The
patients were divided in 2 groups according to the presence of IH.
Group 1 was composed of 32 patients with IH; Group 2 (control
group) was composed of 20 patients with no evidence of IH.
The exclusion criteria was the presence urinary tract
infection, urethral stricture, prostate cancer, a past history of
abdominal surgery, previous therapy for voiding dysfunction during
the last 3 months, or taking medications that could affect the lower
urinary tract.
The study was conducted with the approval of the local
Research Ethics Committee, and all patients consented to
participate.
LUTS were quantified using the 7 question IPSS and the
patients were classified as having mild, moderate or severe
symptoms according the final IPSS score: IPSS from 0 to 7 – mild
symptoms; IPSS from 8 to 19 – moderate symptoms; IPSS > 20,
severe symptom. IH was detected by physical examination by 2
physicians.
Noninvasive parameters of evaluation included
uroflowmetry - peak urinary flow rate (Qmax), post-void residual
(PVR) and measurement of prostate volume (PV) by transrectal
ultrasound. Uroflowmetry was considered a valid test if the voided
volume was not less than 150 ml.
Statistical analyses were performed using the Statistical
Package for the Social Sciences (SPSS® v17.0). The power of
associations between the quantitative variables was determined
using a Pearson’s linear correlation. Two-sided p-values < 0.05
were considered significant. Chi-square test, Student t test were
calculated to compare the matched groups in this study.
Results
The baseline characteristics for Groups 1 and 2 are
summarized in Table 1.
Mild, moderate and severe LUTS were present in 4
(12.5%); 16 (50%) and 12 (n=37.5%) patients of Group 1 (patients
with IH) and in 6 (30%); 9 (45%) and 5 (20%) patients of Group 2
(patients without IH). The presence of IH correlated with the
presence of higher IPSS (r = 0.38 p<0.05) despite the incidence of
patients with mild, moderate and severe LUTS did not differ
significantly in both groups. Table 2 summarizes the symptom
severity distribution between groups 1 and 2.
 
Group 1  
(n = 32) 
Group 2  
(n=20) 
t p 
Age: mean / range / 
SD 
65.2 (55 – 81) 
± 7.4 
63.4 (55 – 74) 
± 6.1 
0.91 0.37 
IPSS: mean / range / 
SD 
20.7 (8 – 32) 
± 7.6 
19.2 (8 – 30) 
± 7.2 
0,71 0.48 
TABLE 1 - Patients baseline characteristics.
TABLE 2 - Symptom severity distribution for groups 1 and 2
(X2=2,61; p=0,27).
The mean values of the noninvasive parameters:
uroflowmetry (Qmax), PVR and PV for Groups 1 and 2 are
summarized in Table 3. A statistically significant difference was
found between the PVR mean values between groups 1 and 2
(p<0.05).
We did not found any correlation between PV, Qmax and
PVR with the LUTS intensity assessed through the IPSS.
Symptom 
Severity 
Mild Moderate Severe 
Group 1 n = 4 (12.5%) n = 16 (50%) n = 12 (37.5%) 
Group 2 n = 6 (30%) n = 9 (45%) n = 5 (20%) 
TABLE 3 - Mean values of the noninvasive parameters in groups
1 and 2.
 Group 1  
(n =32) 
Mean ± SD 
Group 2  
( n = 20) 
Mean ± SD 
t p 
Qmax (ml/sec) 11.4 ± 2.9 12.6 ± 3.1 -1.41 0.16 
PVR (ml) 55.6 ± 29.3 37.8 ± 22.3 2.48 0.02
PV (ml): mean / SD 48.9 ± 11.4 50.7 ± 9.4 0.59 0.56 
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Discussion
Symptoms from lower urinary tract are non specific and
difficult to link to a specific process. However, LUTS represent
the most common clinical manifestation of BPH. Abrams reported
that the fear for cancer, the urinary symptoms which many patients
fear may get worse and necessitate treatment later, and the
bothersome of urinary symptoms affecting quality of life, are the
most frequent reasons that results in medical consultation8.
Recent reports have uncovered a remarkable association
of BPH, erectile dysfunction and chronic pelvic pain syndrome9.
These facts raised an important question: Should BPH be
considered the primary mechanism of lower urinary tract
dysfunction or just one component of the aging process affecting
men?
In the early 19th century, the cause of herniation was
speculated upon and was considered to be due to ‘‘a mechanical
disparity between the visceral pressure and the resistance of the
abdominal musculature’’ and also due to ‘‘the strength of an
abdominal wall which was considered to be diminished by
deficiency, debility or aging’’ A common set of factors that were
often evoked as causative in the genesis of a hernia were: cough,
obesity, constipation, benign prostatic hypertrophy, pregnancy,
ascites, and heavy lifting.
Today we have progressed from the simple concept of
increased intra-abdominal pressure overwhelming a weak
abdominal wall to the complex malady that calls upon several basic
sciences to explain the multitudinous facets, though one final
common pathway, of its pathophysiology. The target organ of all
the known injurious stimuli is the collagen matrix, which is also
related to the aging process in bladder and others organs10.
To our knowledge, our study is the first to evaluate for
the correlation between the LUTS quantified through the IPSS
and presence of IH.
Many authors reported the lack of correlation or a poor
correlation between prostate size estimate by Trus and Luts11,12.
Different methods can be applied to estimate prostate volume.
Digital rectum examination (DRE) is the most inexpensive and
non invasive method but its accuracy with prostate size is poor13.
In a study comparing the accuracy of DRE and TRUS to estimate
prostate volume, Meyhoff et al.14 confirmed the superiority of
TRUS compared to DRE to assess prostate size. We did not find a
positive correlation between prostate volume and the presence
LUTS.
We did not found a statistically significance difference
between the number of men with mild, moderate and severe LUTS
symptoms between groups 1 and 2, but the presence of IH
correlated with a higher IPSS.
A possible explanation for this association remains on
the fact that patients with obstructive voiding dysfunction may
need to strain to void, this effort over time may have a direct impact
on the abdominal wall contributing to the development of IH,
another possibility remains on the fact that IH and BPH are part of
the aging process which incorporates other  functional and
anatomic disorders, if all these changes have a cause effect relation
or are independent factors just related to the aging process, are
still to be defined.
The statistically significance difference found between
the mean PVR values between groups 1 and 2 cannot be
extrapolated to diagnose BOO or associate to BPH related
complications. Uroflowmetry and PVR are recognized as
noninvasive screening tests that can show if voiding is normal or
abnormal, their results cannot be extrapolated. In fact the maximum
flow rate is a function of detrusor contraction and de degree of
BOO and is impossible to distinguish safely patients with BOO
from those with detrusor underactivity5,15,16. There are limited data
regarding the normal residual urine volume in asymptomatic
patients and until now no consensus has been reached to the
relationship between residual urine, BOO and detrusor
underactivity. In addition, the residual urine volume can vary over
time especially in elderly patients17.
The incidence of IH in men undergoing prostatic surgery
is 15-25%, in addition 11-30% of patients who were submitted to
surgical IH repair and presented LUTS precipitate postoperative
retention requiring urological intervention18-20. Urologists should
be aware of this association and advise their patients of the possible
consequences.
The main shortcoming of the present study is the presence
of small number of patients, which must be expanded in the future
to confirm our findings.
Further studies are necessary to investigate if men with
IH and complaining of urinary symptoms related to BPH have a
higher risk to present urodynamic BOO and are more suitable to
BPH related complications or if the presence of LUTS predispose
the development of IH.
Conclusion
Patients with IH present higher IPSS when compared with
patients without IH. Urologists should be aware of this association.
The role of IPSS as a marker to predict the development of clinical
IH still to be determined.
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